Vir Biotechnology's total assets for Q4 2024 were $1.40B, a decrease of -6.64% from the previous quarter. VIR total liabilities were $248.43M for the fiscal quarter, a -3.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.